Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22711,96,1.00 [0.79-1.26],0.9861839200869422
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23324,173,0.99 [0.83-1.18],0.9052734910412472
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23098,1131,1.01 [0.94-1.08],0.8128373574684818
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Candidiasis,23348,407,1.01 [0.90-1.13],0.8513042453457662
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22621,2949,1.00 [0.96-1.04],0.8801540979910425
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22836,2413,1.02 [0.97-1.07],0.4186104145537017
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23114,1143,0.96 [0.89-1.02],0.1981662218578795
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23256,76,1.16 [0.92-1.46],0.2177138341139553
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21808,671,0.98 [0.90-1.07],0.7032611688158408
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,775,0.97 [0.89-1.05],0.4465597400355638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21123,214,0.98 [0.84-1.15],0.8202577274984735
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16352,1382,1.02 [0.96-1.08],0.5249504465295489
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20938,315,1.06 [0.93-1.20],0.3737563832302942
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23296,1325,0.96 [0.90-1.02],0.1939651410705506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Mycoses,23399,458,1.00 [0.89-1.11],0.9314377385772088
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22766,799,1.04 [0.96-1.13],0.3164216740462269
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23353,738,0.99 [0.91-1.08],0.7887750997605765
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22144,173,0.99 [0.83-1.17],0.8660567372707696
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23457,37,0.91 [0.60-1.37],0.6493875907887976
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23267,652,1.00 [0.91-1.09],0.9507415896493252
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23254,74,0.91 [0.68-1.20],0.4949647936459792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23372,163,1.03 [0.87-1.22],0.7249671281928878
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23358,149,1.02 [0.85-1.23],0.8014481928291151
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22250,283,0.95 [0.82-1.09],0.4745876955945111
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22192,225,0.93 [0.79-1.09],0.3562830736774558
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22071,100,1.02 [0.82-1.28],0.8461491692595271
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23434,32,1.13 [0.79-1.63],0.4961245074231902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23390,139,0.93 [0.76-1.14],0.5090607064780039
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Viral warts,23290,39,0.69 [0.44-1.09],0.1122093002198356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23321,70,1.11 [0.86-1.41],0.4246098644576507
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm,23214,200,1.02 [0.87-1.19],0.7941245352353474
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23365,57,1.03 [0.77-1.38],0.8236122443817544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23358,58,1.15 [0.89-1.49],0.2937895050823387
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23204,1028,0.99 [0.92-1.06],0.8280474588809491
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of meninges,23433,74,1.20 [0.97-1.49],0.0946693246566621
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23399,58,1.04 [0.79-1.39],0.7665857064747239
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23426,114,1.05 [0.86-1.29],0.6184169517173225
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm of ovary,23387,148,0.95 [0.78-1.15],0.5744902385191297
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23437,230,0.94 [0.81-1.10],0.4606283327949689
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Caecum,23444,212,0.84 [0.70-1.00],0.0545080502129177
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23377,56,0.88 [0.63-1.23],0.4476985492686037
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Descending colon,23442,130,0.88 [0.71-1.10],0.2639450592568483
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Rectum,23403,237,1.07 [0.94-1.23],0.315447508118081
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23357,427,1.03 [0.93-1.15],0.5516023225553266
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23442,244,0.78 [0.66-0.93],0.0057689858211667
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Carcinoma in situ of breast,19003,118,0.90 [0.72-1.12],0.3418450098840776
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19073,136,0.98 [0.80-1.19],0.8008257046067248
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19070,31,1.10 [0.76-1.60],0.6033848086488338
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19095,56,1.05 [0.79-1.41],0.7255519934732084
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23396,123,0.92 [0.74-1.14],0.4498391647556802
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Haemangioma, any site",23397,121,0.94 [0.75-1.16],0.545077106272225
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Leiomyoma of uterus,22605,487,0.99 [0.90-1.10],0.8718169336677731
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lung cancer and mesothelioma,16845,271,0.94 [0.81-1.09],0.4209845666316715
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Lymphoid leukaemia,19072,33,1.22 [0.88-1.69],0.2370821138834658
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19191,152,0.99 [0.83-1.19],0.9570671515043084
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19133,94,0.99 [0.78-1.26],0.9495984319173038
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19204,165,1.03 [0.86-1.22],0.7728700921026944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19099,60,1.14 [0.87-1.48],0.3398714509917625
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19100,61,1.08 [0.82-1.42],0.5952343495993964
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19088,49,0.93 [0.65-1.32],0.6776175129421642
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19161,122,0.87 [0.69-1.09],0.2287883121070489
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19128,89,1.02 [0.80-1.29],0.8900429885373792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19110,71,1.29 [1.05-1.58],0.0169815175916202
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19073,34,0.79 [0.50-1.26],0.3234938985073768
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19109,70,1.02 [0.78-1.33],0.909683027537407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi,23230,204,1.16 [1.01-1.33],0.0302259171770813
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanocytic naevi of trunk,23421,69,1.26 [1.02-1.55],0.0331885245500386
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Melanoma in situ,19066,75,1.26 [1.02-1.55],0.0316708839356178
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19108,69,1.08 [0.84-1.40],0.5425870243379216
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19168,129,1.05 [0.86-1.27],0.6340184682894299
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19240,201,0.96 [0.81-1.14],0.619462502898507
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19119,80,1.12 [0.89-1.41],0.3205761637123802
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,Other benign neoplasms of skin,23264,149,0.97 [0.80-1.17],0.7194750574993808
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19827,788,1.01 [0.93-1.09],0.8743863348001718
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19862,823,1.02 [0.94-1.10],0.6630865267967896
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23184,330,0.94 [0.83-1.07],0.3679396585126645
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21758,83,1.01 [0.79-1.30],0.9417789471505008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22922,68,1.00 [0.76-1.32],0.9857326838278055
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22589,2521,1.06 [1.02-1.11],0.0060169616905594
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22086,27,0.75 [0.44-1.29],0.300241369282432
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23115,43,1.25 [0.95-1.65],0.1165503713957284
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22956,1281,1.05 [0.99-1.12],0.0968928418029816
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22956,1281,1.05 [0.99-1.12],0.0968928418029816
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21741,66,1.15 [0.90-1.47],0.2683351690070429
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23107,1048,1.05 [0.98-1.12],0.1423635525016856
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23173,101,1.24 [1.04-1.49],0.0188687871862523
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22897,43,1.03 [0.73-1.44],0.8842318634978155
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22906,52,1.17 [0.90-1.52],0.2512997523161021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23270,198,0.96 [0.81-1.14],0.6448949533855235
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23362,53,1.16 [0.89-1.52],0.2638800324842504
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23240,168,0.92 [0.76-1.11],0.3679797522579209
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22171,112,0.95 [0.76-1.19],0.6680104004836718
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18899,203,0.88 [0.74-1.05],0.1652062585016068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22241,55,1.07 [0.80-1.43],0.64804001739232
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22240,54,1.17 [0.89-1.54],0.2536264029537959
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18739,43,0.89 [0.61-1.30],0.5601114821916927
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21525,53,0.91 [0.65-1.28],0.596447947789346
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21225,210,0.90 [0.76-1.07],0.252259744443538
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23084,405,0.84 [0.74-0.96],0.0095172853008978
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22931,252,1.00 [0.86-1.16],0.992082526641129
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22737,58,1.10 [0.83-1.45],0.5005483904089453
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23133,1661,1.03 [0.98-1.09],0.2388059463133879
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20803,1624,1.03 [0.97-1.08],0.362382445093065
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18743,47,1.16 [0.87-1.55],0.3236246193963116
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20854,101,1.17 [0.96-1.42],0.1267743124370235
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18940,244,1.04 [0.90-1.20],0.5824155238065009
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18737,41,0.95 [0.67-1.37],0.802885882968392
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21378,2682,1.02 [0.98-1.07],0.3198641074069787
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18876,180,0.85 [0.70-1.03],0.1026601670333812
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19165,469,0.99 [0.89-1.10],0.860872478063974
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23375,306,1.15 [1.03-1.29],0.0140309671244249
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23212,143,1.20 [1.02-1.41],0.0279063533176884
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18784,88,0.98 [0.76-1.25],0.8519142371279229
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18745,49,1.00 [0.73-1.38],0.9995080127994426
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22710,1957,1.02 [0.97-1.08],0.3667558264382756
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18867,171,0.77 [0.63-0.95],0.0155377702133324
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18864,168,1.12 [0.95-1.32],0.1633401978544506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19153,457,0.96 [0.86-1.07],0.4907191488429575
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18764,68,0.67 [0.47-0.96],0.0281518469714581
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23206,137,1.19 [1.00-1.40],0.0460253137534917
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19220,524,1.02 [0.92-1.12],0.7195021129628539
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19169,473,0.95 [0.85-1.06],0.3522669003515394
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21077,62,0.93 [0.68-1.26],0.6369531772746484
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22707,4011,1.02 [0.98-1.05],0.3345558249615181
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20815,62,0.99 [0.74-1.32],0.9356279619776804
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20830,77,1.10 [0.87-1.39],0.4253632954129642
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23294,1758,0.96 [0.91-1.02],0.1519215308781431
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23298,1757,0.96 [0.91-1.02],0.1609966613486858
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20824,71,1.14 [0.89-1.45],0.2967087697420761
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23104,1348,1.00 [0.94-1.06],0.984200064994498
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19971,1275,0.99 [0.92-1.05],0.6693459437443006
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23448,152,1.11 [0.93-1.32],0.2419635649143446
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22720,41,0.98 [0.68-1.41],0.914030640763913
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21871,115,0.96 [0.78-1.20],0.7423774018919251
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21924,168,1.08 [0.92-1.27],0.3485030429224129
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18910,214,1.07 [0.92-1.23],0.3921193521775827
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21901,118,0.98 [0.79-1.21],0.83020874959651
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1448,37,1.02 [0.70-1.49],0.9173443631641582
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1541,149,1.15 [0.96-1.38],0.1253866752787301
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21807,24,1.17 [0.77-1.78],0.4713080370746358
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1432,22,0.89 [0.51-1.56],0.6959156919445787
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23053,1270,0.97 [0.91-1.04],0.382776838811786
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22964,285,0.97 [0.85-1.12],0.7180966675312481
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21427,412,0.96 [0.86-1.08],0.5307678985554236
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19302,606,0.99 [0.90-1.08],0.7787269619356374
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23371,206,0.85 [0.71-1.02],0.0747462713680778
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22573,45,1.03 [0.73-1.45],0.8866548931443964
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Angina pectoris,22158,729,0.95 [0.87-1.04],0.2900722398425459
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22609,81,0.89 [0.67-1.18],0.40808674705808
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22558,30,1.23 [0.86-1.77],0.2586897493974814
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22666,138,0.95 [0.78-1.17],0.6551750359997449
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15241,1238,1.02 [0.96-1.09],0.4893270845080155
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,AV-block,20580,205,1.02 [0.87-1.19],0.8389266968440285
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23415,260,0.90 [0.77-1.05],0.1703037747642221
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiac arrest,14109,106,1.10 [0.89-1.35],0.3840187938602679
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cardiomyopathy,20495,120,0.96 [0.77-1.18],0.6761565991913292
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20448,73,1.04 [0.81-1.34],0.7632344538330016
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23454,26,1.46 [1.06-2.00],0.0195180989857674
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Conduction disorders,20994,619,1.05 [0.96-1.14],0.3139981621638769
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22681,1261,1.00 [0.94-1.07],0.9766537210813638
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21106,6213,1.01 [0.98-1.04],0.696321322152635
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22181,219,0.88 [0.74-1.04],0.1283021642002015
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Endocarditis,20420,45,1.02 [0.73-1.42],0.8977851815153349
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23375,706,1.03 [0.95-1.12],0.5038519385661382
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertension,21636,5222,1.01 [0.98-1.04],0.6110138871383561
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21644,5230,1.01 [0.98-1.04],0.6263065636241811
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23359,34,0.84 [0.53-1.31],0.4354737452266884
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16562,148,1.05 [0.87-1.26],0.6212594872905421
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16479,65,1.09 [0.84-1.43],0.5179685816940588
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Hypotension,23342,907,0.96 [0.89-1.04],0.323753486532965
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22820,81,1.11 [0.88-1.40],0.3733997594412443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22855,1426,1.01 [0.95-1.07],0.8309903008132022
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23192,382,1.08 [0.96-1.20],0.1964289707562052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Left bundle-branch block,20637,262,1.09 [0.96-1.25],0.1796323515298675
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23271,517,1.04 [0.94-1.15],0.4436625495494054
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21846,417,1.07 [0.96-1.19],0.2095357308251597
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23433,76,1.27 [1.03-1.57],0.0230287132598393
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23449,209,1.05 [0.90-1.23],0.510035062005973
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Oesophageal varices,21995,33,0.72 [0.44-1.18],0.1914637881671379
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other aneurysm,22578,50,0.90 [0.64-1.27],0.5542774850905791
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arrhythmias,20680,305,0.90 [0.78-1.03],0.1245791333183787
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22589,61,1.04 [0.78-1.39],0.7695792097369555
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22701,173,1.17 [1.01-1.36],0.0380771398972283
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20521,146,0.96 [0.79-1.16],0.6599870752058141
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other disorders of veins,22037,75,0.75 [0.55-1.04],0.0810387133864965
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22003,41,0.97 [0.68-1.39],0.8742887948648058
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22403,32,0.69 [0.42-1.15],0.1579378249594291
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22092,130,1.02 [0.84-1.25],0.8155089268867532
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21040,665,1.01 [0.92-1.10],0.8870331672031417
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22472,37,1.09 [0.77-1.54],0.6318437647402061
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22968,440,0.97 [0.86-1.08],0.5380914499943219
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22957,278,1.06 [0.93-1.21],0.3860148378978542
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22824,453,0.93 [0.83-1.04],0.2142008264664718
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14251,248,1.08 [0.95-1.24],0.2456154189700591
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22761,243,0.95 [0.81-1.11],0.5043821100517385
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22246,284,0.97 [0.85-1.12],0.7118653974349443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23056,377,1.00 [0.88-1.12],0.9481719290165715
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23387,491,1.01 [0.91-1.12],0.8842486117795116
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Right bundle-branch block,20557,182,1.08 [0.92-1.26],0.3397104484147198
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22951,272,1.08 [0.95-1.23],0.2528421530961123
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22501,130,1.08 [0.89-1.30],0.4386990159107352
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23183,444,1.07 [0.97-1.19],0.1958844042016982
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23161,484,1.05 [0.95-1.17],0.2984154094285906
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22793,61,1.08 [0.83-1.42],0.5627152618797351
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22564,36,0.84 [0.55-1.29],0.4306886414251482
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22987,177,1.06 [0.90-1.25],0.4984546836277052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22925,171,0.95 [0.79-1.15],0.6124311546797021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Varicose veins,22335,373,1.08 [0.97-1.20],0.1834615889398435
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22538,82,0.85 [0.64-1.13],0.2601082197037965
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23273,599,0.98 [0.89-1.08],0.6707756442502474
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23420,192,0.99 [0.84-1.16],0.8724580718996188
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20862,1575,1.01 [0.95-1.06],0.8192399209152109
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Any mental disorder,22951,3664,1.01 [0.98-1.05],0.4495927690311595
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23394,224,1.00 [0.86-1.16],0.9996050974433508
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20964,1677,1.03 [0.97-1.08],0.3595077751638842
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19364,77,0.94 [0.71-1.23],0.6281095981360243
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Smoking dependency,23110,1015,0.99 [0.92-1.06],0.7289961505194377
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20461,1174,0.98 [0.92-1.05],0.5890878336366472
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter V Mental and behavioural disorders,Vascular dementia,23043,91,0.91 [0.70-1.19],0.4929189893618316
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Alzheimer disease,23455,313,0.97 [0.85-1.11],0.6972070651701823
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",16087,51,0.80 [0.54-1.18],0.2596231529975716
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Bell's palsy,21631,72,0.88 [0.65-1.17],0.3747955323624483
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22097,538,0.96 [0.87-1.06],0.4390519695900008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral cysts,23111,187,0.98 [0.83-1.16],0.8263982879744287
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23393,229,1.07 [0.92-1.23],0.3720076245909463
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23046,36,0.97 [0.66-1.44],0.8901245294596192
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23444,43,0.93 [0.64-1.34],0.6852699863770468
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22969,45,0.92 [0.64-1.32],0.6431550712164706
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Epilepsy,22212,236,1.06 [0.92-1.22],0.4166781915827048
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23095,1119,1.03 [0.97-1.10],0.304945405412571
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23412,300,1.00 [0.88-1.14],0.9772008038160602
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22923,2449,0.97 [0.93-1.02],0.2837525993245852
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Generalized epilepsy,23147,40,1.08 [0.77-1.51],0.6730567722662765
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hemiplegia,23346,182,1.12 [0.96-1.31],0.1551830486967601
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Hydrocephalus,22980,56,1.17 [0.90-1.52],0.2479680216632187
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23438,67,0.96 [0.72-1.28],0.7905297313680595
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21665,106,1.08 [0.88-1.32],0.4560400407597422
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21614,55,0.98 [0.72-1.34],0.9220133834810308
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Memory loss,22935,92,0.93 [0.73-1.20],0.5952179028177792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Migraine,22409,433,1.00 [0.90-1.11],0.9927463453339944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23359,393,1.00 [0.90-1.12],0.9572384762581264
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Motor neuron disease,16172,112,0.94 [0.75-1.17],0.5694668529994578
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23264,121,1.08 [0.89-1.30],0.4410654893985585
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22743,1184,0.99 [0.93-1.06],0.7825398592705606
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Neurological diseases,22071,3143,1.00 [0.96-1.04],0.963955151370978
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23132,122,0.97 [0.78-1.20],0.7848360056972301
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21920,361,0.98 [0.87-1.11],0.7469805846045543
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23408,196,1.07 [0.92-1.25],0.38012451001067
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18981,558,0.99 [0.90-1.09],0.8636213409647919
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22981,57,1.12 [0.85-1.47],0.4297857695071686
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23032,108,0.98 [0.79-1.23],0.888054892440688
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23251,139,1.01 [0.83-1.22],0.9486015533350132
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other facial nerve disorders,21639,80,0.87 [0.66-1.15],0.3361115753482297
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other headache syndromes,22045,69,1.06 [0.82-1.37],0.6384166005721847
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other neurological diseases,23353,429,1.04 [0.94-1.16],0.4345346620189605
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Other sleep disorders,22312,336,1.03 [0.91-1.16],0.6678346438059661
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Parkinson's disease,23433,141,0.97 [0.79-1.18],0.7378730692266253
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22995,71,1.01 [0.77-1.31],0.9609992285333564
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Restless leg syndrome,23454,75,1.01 [0.78-1.31],0.94181701882257
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,272,1.03 [0.90-1.18],0.6454301997019815
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23245,33,1.11 [0.77-1.60],0.5739892788821637
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23445,136,0.81 [0.65-1.02],0.0719786511612936
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21616,57,1.22 [0.95-1.57],0.1207618631133578
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23455,316,0.98 [0.86-1.12],0.7324373589777
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23004,88,0.91 [0.69-1.19],0.4742026856476599
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22943,93,0.98 [0.77-1.25],0.8903508696354544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23064,423,0.98 [0.87-1.09],0.6811999335547783
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23331,141,1.06 [0.88-1.28],0.5571491138848157
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22502,51,1.24 [0.96-1.60],0.0986076782689027
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22498,47,0.96 [0.69-1.34],0.794821565324589
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23344,55,0.95 [0.69-1.32],0.7751903014005337
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23214,148,0.81 [0.65-1.01],0.0666382559774358
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1439,28,1.15 [0.76-1.74],0.5101797070462663
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1727,54,1.11 [0.83-1.49],0.4832085344514278
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22934,84,0.98 [0.76-1.26],0.8649290638063848
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23307,896,1.03 [0.96-1.11],0.4042480316484094
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23093,642,0.99 [0.90-1.08],0.7812168626854984
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22709,258,1.10 [0.96-1.25],0.1592371050767345
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23380,739,1.00 [0.92-1.08],0.9491795323585148
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23443,62,1.06 [0.81-1.39],0.6673911306484328
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23317,676,1.00 [0.91-1.09],0.9483200797979908
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23417,351,0.86 [0.75-0.98],0.028032476247801
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23376,180,0.78 [0.64-0.96],0.0166344339045846
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22489,38,0.87 [0.58-1.32],0.5123729105143324
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22492,41,0.88 [0.59-1.31],0.5293008776387522
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22512,61,1.16 [0.90-1.50],0.2411835776580955
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23381,609,0.97 [0.88-1.07],0.516060720460713
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22923,151,0.91 [0.74-1.11],0.3461723730249705
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22694,53,1.20 [0.92-1.56],0.1863543063985739
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23150,84,0.80 [0.59-1.07],0.1253243446957615
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23342,276,0.88 [0.75-1.02],0.0949251292218378
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22824,183,1.00 [0.85-1.18],0.9774920087191064
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23312,116,0.61 [0.46-0.80],0.0005088494625962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23169,397,0.99 [0.89-1.12],0.9305323122574664
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22985,135,0.95 [0.78-1.16],0.625818060052859
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21921,2165,1.01 [0.96-1.06],0.6068888171686866
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23308,242,0.89 [0.76-1.05],0.1667398172934008
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23433,139,0.98 [0.81-1.20],0.8639265135844476
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22785,334,0.98 [0.87-1.11],0.7685696241191301
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23121,55,0.65 [0.43-0.97],0.0357379167875672
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23430,49,1.13 [0.84-1.51],0.416410793355825
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22532,81,1.15 [0.92-1.44],0.2211069497691789
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22579,128,0.99 [0.81-1.22],0.9589516559560984
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22498,87,1.15 [0.93-1.44],0.1966077295285415
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22695,54,1.06 [0.79-1.42],0.686010455964037
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22465,54,0.83 [0.58-1.18],0.2927639173116909
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22872,100,0.81 [0.62-1.05],0.1112264458206323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22928,156,0.85 [0.69-1.04],0.122549420162645
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22562,111,0.91 [0.72-1.14],0.3988246411947653
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22491,80,1.17 [0.95-1.45],0.148826886264733
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22467,56,1.00 [0.73-1.36],0.99487026173033
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21539,1783,0.99 [0.94-1.05],0.7772734671297399
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22528,77,1.14 [0.91-1.43],0.2447299398360387
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23225,375,0.99 [0.88-1.11],0.8078406069310142
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22889,39,0.97 [0.66-1.42],0.8667702076107751
USP47,Ubiquitin carboxyl-terminal hydrolase 47,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22998,148,1.03 [0.86-1.24],0.7222516047321081
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23237,99,0.94 [0.74-1.20],0.6278325083585206
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23415,94,0.91 [0.71-1.17],0.4597859080489729
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23351,122,1.04 [0.85-1.26],0.7258725783561973
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23200,62,1.11 [0.85-1.44],0.4481846611763881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23203,65,0.93 [0.69-1.25],0.6163684622190739
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23364,680,0.99 [0.91-1.09],0.9076974942985696
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23150,466,1.02 [0.92-1.13],0.7405348348645489
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22784,100,1.24 [1.03-1.50],0.0217918878529014
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22756,72,1.03 [0.79-1.33],0.8269749127770791
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute pharyngitis,23212,75,0.86 [0.65-1.15],0.3210986900468824
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23343,206,0.85 [0.72-1.02],0.0749315657341028
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23192,55,0.91 [0.66-1.25],0.5479381064985394
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza,22017,108,1.10 [0.90-1.35],0.3304565282124173
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22016,107,1.12 [0.92-1.37],0.2695853584702655
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic asthma (mode),16685,111,1.19 [1.00-1.42],0.0495041630554679
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Allergic rhinitis,23331,242,1.01 [0.88-1.16],0.8924062172647576
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18210,1792,0.99 [0.94-1.04],0.6502348061189624
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18345,1771,0.98 [0.93-1.04],0.5034270508902208
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23107,114,0.99 [0.80-1.23],0.9272344872001366
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21970,61,1.11 [0.85-1.44],0.4533480261251312
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Bronchiectasis,20256,345,1.07 [0.95-1.20],0.2430601988552798
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19968,57,1.12 [0.85-1.47],0.424134406128961
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22470,2559,1.00 [0.96-1.05],0.8446104328559055
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22359,56,0.85 [0.60-1.19],0.330174552231323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Chronic sinusitis,22426,123,1.04 [0.85-1.26],0.7170701602883516
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23306,886,0.99 [0.92-1.07],0.8586048802889712
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Deviated nasal septum,22368,65,0.97 [0.73-1.29],0.8248120372550816
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21658,4386,1.01 [0.97-1.04],0.6910827524686658
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22596,293,0.94 [0.82-1.08],0.4010003252576484
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Early onset COPD,22692,272,0.99 [0.86-1.13],0.8300091266276066
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Emphysema,20139,228,1.09 [0.94-1.27],0.2462158695332311
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22017,197,1.09 [0.94-1.27],0.2362097282553902
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23284,1375,0.98 [0.92-1.05],0.5708862287837114
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Interstitial lung disease,22051,231,1.05 [0.91-1.21],0.4841594935924694
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Later onset COPD,22664,614,1.00 [0.91-1.10],0.9598094659025348
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23449,180,1.11 [0.95-1.30],0.1733270599611994
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Nasal polyp,22361,58,1.12 [0.86-1.46],0.4100791954917406
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23255,793,0.98 [0.91-1.07],0.6767233394116557
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of pleura,23294,1479,1.00 [0.94-1.06],0.9518694453706532
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22976,673,1.02 [0.94-1.11],0.6566833947484514
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other pleural conditions,21849,34,0.91 [0.60-1.38],0.6529862054653881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23381,293,1.00 [0.87-1.14],0.9619521726109423
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23379,1005,1.01 [0.94-1.09],0.7299389367520339
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural effusion,22518,703,0.97 [0.89-1.06],0.4611146854037548
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pleural plaque,21856,41,1.08 [0.79-1.48],0.6178813149997595
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23076,1167,0.96 [0.90-1.03],0.2494347453935756
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23424,155,1.08 [0.91-1.28],0.4055740736617103
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pneumothorax,21901,86,0.88 [0.67-1.15],0.3473535236723323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pollen allergy,23430,203,1.01 [0.86-1.17],0.9446002863971088
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Pulmonary oedema,23142,54,0.86 [0.60-1.22],0.3938120907656488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Respiratory insufficiency,16618,44,1.14 [0.86-1.51],0.3592687414664884
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23236,774,0.98 [0.90-1.07],0.6328856992325236
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22545,242,1.01 [0.88-1.16],0.8859846387494363
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Viral pneumonia,22091,182,0.91 [0.76-1.10],0.3353078268850772
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23116,145,0.86 [0.69-1.06],0.1553421221820101
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11308,89,0.92 [0.71-1.18],0.50168411132489
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16779,36,0.92 [0.61-1.37],0.6645945561441096
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute appendicitis,23289,120,0.90 [0.72-1.12],0.3442414374509427
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute gastritis,17614,72,0.98 [0.75-1.28],0.8875766612031021
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute pancreatitis,21502,140,1.06 [0.89-1.28],0.4962146498692231
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Acute peritonitis,22973,73,1.14 [0.90-1.44],0.2909753088185851
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Alcoholic liver disease,22714,30,0.61 [0.35-1.06],0.0801426097682619
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Barrett oesophagus,17839,297,0.97 [0.85-1.11],0.6843766494862633
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21430,68,1.32 [1.08-1.62],0.0080630766129985
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23104,68,1.33 [1.08-1.63],0.0074296819056391
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholecystitis,21515,153,0.98 [0.81-1.18],0.8451685011312389
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Cholelithiasis,22385,1023,0.99 [0.92-1.07],0.8310159676006269
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic gastritis,17831,289,1.04 [0.92-1.18],0.5462652224855612
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Chronic pancreatitis,21395,33,0.69 [0.42-1.14],0.1460513242270605
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23388,63,0.86 [0.62-1.19],0.3629486186411521
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Coeliac disease,22144,128,1.21 [1.03-1.42],0.0238044543370311
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Collagenous colitis,21838,95,0.73 [0.55-0.97],0.0310136606610534
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23333,134,1.02 [0.84-1.23],0.8771007208053075
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Constipation,23166,1453,0.97 [0.91-1.03],0.3038274288408971
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn disease,21812,69,1.16 [0.91-1.46],0.2254432349692932
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23154,49,1.23 [0.95-1.61],0.1196118708249708
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Crohn's disease NAS,21816,73,1.15 [0.91-1.45],0.2391629842419399
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Dental caries,22750,202,1.02 [0.88-1.19],0.7803053853627606
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22058,2092,1.00 [0.95-1.05],0.8536597650077944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of appendix,23327,158,1.04 [0.87-1.23],0.6745505501817175
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of liver,23372,688,1.01 [0.92-1.10],0.860967286569527
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21490,3948,0.98 [0.94-1.02],0.2614070087760476
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23060,512,1.09 [1.00-1.20],0.0519104972804715
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23350,450,1.06 [0.96-1.17],0.2615944490327443
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22649,101,1.00 [0.80-1.25],0.994010581649962
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22521,55,0.76 [0.53-1.09],0.136698027312318
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23203,1187,1.01 [0.95-1.08],0.7823419798552352
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diseases of tongue,22526,89,1.00 [0.79-1.27],0.9764088710157603
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22723,1361,1.00 [0.94-1.07],0.952486230392664
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19480,2737,1.00 [0.96-1.05],0.9038623169880065
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Duodenal ulcer,17658,116,0.98 [0.79-1.21],0.8372186222591709
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23408,96,0.99 [0.79-1.25],0.9611737673071388
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23369,57,1.21 [0.95-1.54],0.1148214288651407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22764,80,0.91 [0.69-1.20],0.5110677516421989
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16841,98,1.12 [0.91-1.37],0.2820377751545163
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Functional dyspepsia,18114,572,0.97 [0.88-1.07],0.5574437950164943
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastric ulcer,17839,297,0.91 [0.79-1.05],0.1783773787236989
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19929,2387,0.97 [0.92-1.01],0.1488830255774347
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17951,409,0.94 [0.83-1.06],0.2929053567237983
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18365,7206,1.00 [0.98-1.03],0.9394596304776068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,GI-bleeding,22959,943,0.99 [0.92-1.07],0.7815265655308277
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22610,62,1.02 [0.77-1.35],0.8698186669368044
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17577,1084,1.07 [1.00-1.14],0.0390727659653394
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22716,32,0.91 [0.58-1.40],0.6587397055307206
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Hernia,22432,2466,0.99 [0.95-1.04],0.7638484423089035
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impacted teeth,23377,52,1.14 [0.87-1.49],0.329285410757598
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Impaction of intestines,16801,58,1.17 [0.91-1.50],0.2106186577785565
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Inguinal hernia,20115,149,1.00 [0.83-1.21],0.9774698752287156
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16829,86,0.91 [0.70-1.18],0.4745299886879666
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22170,154,1.14 [0.97-1.34],0.111777204338774
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17435,692,0.96 [0.88-1.05],0.3923936765696584
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23445,297,1.08 [0.95-1.22],0.2411684434672728
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22447,704,1.08 [1.00-1.17],0.0581475931798215
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22683,940,1.03 [0.96-1.11],0.36904920687171
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17674,132,0.90 [0.73-1.11],0.3435418683239347
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oesophagitis,18032,490,0.97 [0.88-1.08],0.5776936354014546
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23418,139,0.82 [0.66-1.03],0.0837580550063003
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20017,51,1.10 [0.82-1.48],0.5201678390014866
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17826,1083,1.04 [0.97-1.11],0.2836772633585323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21611,249,1.03 [0.89-1.19],0.6792473821697097
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21521,159,1.02 [0.86-1.22],0.8241553204331928
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestine,18101,1358,1.00 [0.94-1.07],0.9055791339894156
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of intestines,21606,4863,1.01 [0.97-1.04],0.7542514957284157
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22531,200,0.82 [0.69-0.99],0.0355645042493337
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of liver,23258,574,1.02 [0.93-1.12],0.7282789422810507
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18050,508,0.99 [0.90-1.09],0.8538312582075068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of pancreas,21493,131,0.91 [0.74-1.13],0.4019212422472716
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23293,393,1.04 [0.93-1.16],0.5088694311593256
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18475,933,0.98 [0.91-1.06],0.6715136656965286
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22975,959,0.99 [0.92-1.07],0.7953308408858041
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22700,152,1.21 [1.04-1.41],0.0137935711609957
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18245,1502,0.98 [0.93-1.04],0.5889760023649748
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19334,1792,0.98 [0.93-1.04],0.4957551545299801
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22772,88,1.05 [0.83-1.32],0.6700790622744759
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22577,834,1.03 [0.96-1.12],0.3740005803647306
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17026,283,0.97 [0.85-1.12],0.7096568687686149
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23361,66,1.29 [1.05-1.59],0.0136360438298044
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17167,424,0.96 [0.86-1.08],0.503010424860974
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22134,118,0.92 [0.73-1.14],0.4344839528541938
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23447,64,0.93 [0.69-1.25],0.6322593650494621
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22550,116,1.00 [0.82-1.24],0.9668815246638648
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Toxic colitis,21797,54,0.89 [0.63-1.25],0.5015328965718864
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17749,207,0.97 [0.82-1.14],0.6956690331469922
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ulcerative colitis,21880,137,0.98 [0.81-1.19],0.8184388005421805
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21856,113,0.97 [0.78-1.20],0.7811489217785696
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Umbilical hernia,20113,147,0.99 [0.82-1.20],0.9356930288631288
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16906,163,1.06 [0.89-1.25],0.5049053699289807
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Ventral hernia,20178,212,1.02 [0.87-1.19],0.8175259259118468
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XI Diseases of the digestive system,Volvulus,16816,73,1.02 [0.79-1.31],0.9071835607156488
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23381,214,1.12 [0.97-1.28],0.1129333824591276
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23176,73,1.03 [0.80-1.33],0.8054457318342163
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21712,193,0.95 [0.80-1.12],0.5352593159150536
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22992,540,0.97 [0.88-1.07],0.5488760985589595
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22580,128,1.08 [0.90-1.30],0.4157986098340162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21786,267,0.96 [0.83-1.11],0.6112716942095952
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23183,243,0.93 [0.80-1.09],0.375758719902667
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23357,417,1.00 [0.90-1.12],0.9998129359112616
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22982,42,1.20 [0.89-1.61],0.2351440725804374
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22078,2701,0.98 [0.93-1.02],0.2944278823782089
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23068,403,0.92 [0.81-1.03],0.1505843742870165
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22941,276,0.93 [0.81-1.07],0.309032141643062
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23179,727,0.97 [0.89-1.05],0.4471038082459173
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23436,67,0.97 [0.73-1.28],0.8189057795505598
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21605,86,0.82 [0.62-1.09],0.1754569805124564
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22705,40,0.93 [0.63-1.35],0.6906524290379341
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23169,229,0.92 [0.78-1.07],0.2793117568977514
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21875,356,1.00 [0.88-1.12],0.9365395002459532
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21565,46,0.83 [0.57-1.22],0.3455167070846017
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23369,68,0.73 [0.52-1.02],0.0644412963509632
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22581,129,1.02 [0.84-1.24],0.8353049937238131
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23250,147,0.73 [0.58-0.92],0.0078454173268129
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22982,42,0.94 [0.65-1.38],0.7672976397287736
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21573,54,0.89 [0.63-1.24],0.4791478094154222
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22870,1351,0.98 [0.92-1.05],0.6078570199383626
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21906,387,0.99 [0.88-1.11],0.8326244326752886
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21567,48,0.87 [0.60-1.25],0.4372039377535243
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23380,277,0.93 [0.81-1.08],0.3433390837067359
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23014,74,0.94 [0.72-1.24],0.6728040216956165
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23316,213,0.91 [0.77-1.07],0.2486012060326955
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23407,240,1.09 [0.95-1.25],0.2050925301837356
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21660,141,0.98 [0.81-1.19],0.8715075495642339
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21742,223,1.05 [0.91-1.21],0.4860636580627858
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23396,229,1.09 [0.95-1.25],0.2168011356462367
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21686,167,1.04 [0.88-1.24],0.63402792872068
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23426,125,0.84 [0.66-1.05],0.1280810431157801
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20014,112,0.93 [0.75-1.16],0.5305589653143516
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21302,5467,1.01 [0.98-1.04],0.7143123642749043
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20124,4289,1.02 [0.98-1.05],0.2926393186250323
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19967,65,1.14 [0.89-1.45],0.3118032867901039
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20128,133,1.02 [0.85-1.24],0.8151464954937626
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20177,182,1.03 [0.88-1.21],0.7304257449526748
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23213,98,0.73 [0.56-0.97],0.0277590363937308
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20096,101,0.86 [0.67-1.11],0.2388544909515943
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17027,1192,0.99 [0.93-1.06],0.8407095098886548
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23319,198,1.07 [0.92-1.25],0.4055379998946391
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20496,501,1.02 [0.92-1.12],0.743034180804494
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19703,6946,1.01 [0.98-1.04],0.5574196052490128
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21025,114,0.87 [0.68-1.10],0.2370470405848474
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20016,114,0.98 [0.79-1.22],0.8824935467938942
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20494,592,1.06 [0.97-1.16],0.188324933872931
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22575,2580,1.01 [0.97-1.06],0.514710616944944
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20057,155,1.11 [0.94-1.30],0.2223011057158396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20236,334,1.09 [0.97-1.22],0.1497170377706873
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20051,149,1.18 [1.01-1.37],0.042031510922774
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22605,95,0.88 [0.68-1.14],0.3186969428719265
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17458,1623,1.02 [0.97-1.08],0.4560135679621632
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16015,180,0.94 [0.79-1.12],0.4825238631774189
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23443,177,0.93 [0.77-1.12],0.4394434603436054
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15925,90,0.94 [0.74-1.21],0.6429917283274404
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16329,494,0.99 [0.89-1.10],0.8435027316016258
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20192,290,0.97 [0.84-1.11],0.6153162928232185
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16388,553,1.00 [0.91-1.10],0.971803872937916
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20053,58,0.95 [0.70-1.30],0.7636392551053605
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20612,617,1.01 [0.92-1.11],0.8026319203109653
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20284,289,1.00 [0.88-1.14],0.9942409322582656
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16349,514,1.02 [0.93-1.13],0.6310490716702941
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19975,73,1.01 [0.78-1.31],0.9136860522318948
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19962,60,1.15 [0.89-1.48],0.2762720547351059
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20953,42,0.95 [0.66-1.37],0.7944541249612427
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23051,2140,1.01 [0.97-1.06],0.5642754317096792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22456,1545,1.03 [0.97-1.09],0.3362534868564948
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23274,503,0.97 [0.87-1.08],0.5589143416880052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18447,2612,1.03 [0.98-1.07],0.2145954923110998
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15896,61,1.09 [0.84-1.42],0.5239892756299096
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19991,89,1.15 [0.93-1.42],0.1919543228023199
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15877,42,1.00 [0.70-1.42],0.980817163104133
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16009,174,1.03 [0.87-1.22],0.7173675090996692
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21163,252,0.93 [0.80-1.08],0.3334702820245692
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21394,483,1.00 [0.90-1.11],0.9807577353389656
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23431,93,1.09 [0.88-1.36],0.4160155677956401
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21745,1750,1.02 [0.97-1.08],0.4586946714676881
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20014,112,0.98 [0.79-1.21],0.846499864380915
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16034,199,0.91 [0.76-1.08],0.26025141991217
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20696,701,0.99 [0.91-1.08],0.8286954189245639
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18023,2188,1.01 [0.96-1.06],0.6814122564541341
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22625,115,1.03 [0.84-1.27],0.7468460755808619
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23437,72,1.08 [0.84-1.38],0.5566919864833266
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19967,65,0.99 [0.75-1.31],0.9353556391127112
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21168,1266,1.03 [0.97-1.10],0.2779382520833536
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19970,68,0.90 [0.66-1.21],0.484487613044854
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17541,1706,1.00 [0.95-1.06],0.9689921135465784
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21034,123,1.08 [0.90-1.30],0.4164832833501091
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19951,49,0.95 [0.69-1.32],0.7709028993357945
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20164,169,0.93 [0.77-1.12],0.4427216294495057
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20392,490,1.00 [0.91-1.11],0.9538134914434052
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22955,445,1.06 [0.95-1.17],0.2922537524688953
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20551,556,0.98 [0.89-1.08],0.7349454840143617
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23286,486,0.96 [0.87-1.07],0.5100622386940634
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23433,58,1.01 [0.75-1.36],0.9567819653121108
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20096,194,1.04 [0.89-1.22],0.5838154478139861
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17957,782,0.99 [0.91-1.07],0.7753766839991667
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20472,570,1.00 [0.91-1.10],0.9372282134466569
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20008,106,1.07 [0.87-1.31],0.5387526733459467
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15906,71,1.02 [0.78-1.34],0.8703951865488848
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18097,2262,1.01 [0.96-1.06],0.7886360137290116
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16557,722,1.02 [0.94-1.11],0.6611272796786319
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22764,254,1.02 [0.89-1.18],0.7403204380951851
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23405,67,0.98 [0.74-1.30],0.8731409237180507
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21480,47,0.98 [0.69-1.39],0.9209939508400774
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15908,73,1.07 [0.84-1.38],0.576921978250243
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20089,94,1.01 [0.81-1.27],0.9075694498000272
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16342,507,0.99 [0.89-1.09],0.7970995258363067
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20179,277,0.95 [0.82-1.09],0.4486808638968045
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20242,247,1.09 [0.96-1.24],0.1996129097799556
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20233,238,1.01 [0.87-1.17],0.8913216739611614
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18074,75,1.00 [0.77-1.29],0.9704988671439514
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23438,63,0.96 [0.71-1.29],0.772673006637407
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20448,546,0.94 [0.85-1.04],0.2664119292985712
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],22655,145,1.13 [0.96-1.34],0.1444912618673655
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22323,2421,1.03 [0.98-1.07],0.2318376440085661
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20036,134,0.77 [0.61-0.97],0.025988461660124
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20478,483,1.04 [0.94-1.14],0.4851505690696195
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21955,218,0.91 [0.77-1.07],0.2559517099687186
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20208,213,1.06 [0.91-1.23],0.4547623032364369
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21480,1485,1.02 [0.96-1.08],0.6131136452543569
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21006,1011,1.01 [0.95-1.09],0.6904497437584792
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19957,55,1.24 [0.97-1.58],0.0816823444177541
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22716,206,0.99 [0.85-1.16],0.9089460401332544
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20073,171,0.93 [0.78-1.12],0.4430561317818263
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20016,114,0.84 [0.66-1.06],0.1463771360567898
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15877,42,1.08 [0.78-1.51],0.6334348192058494
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22627,1026,1.00 [0.93-1.08],0.9911716861895506
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17527,85,1.03 [0.81-1.30],0.8244936091023864
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22857,97,1.00 [0.79-1.25],0.9671376529219384
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23323,199,1.06 [0.91-1.23],0.459243871792358
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23147,23,0.53 [0.27-1.03],0.0592707725356656
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22745,1144,1.02 [0.96-1.09],0.5220699762183001
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23316,58,0.88 [0.63-1.23],0.4537124239097287
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23290,198,0.88 [0.74-1.05],0.1646085606818031
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Cystitis,20714,213,1.02 [0.88-1.19],0.8042193172871523
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Dialysis,21646,45,1.13 [0.83-1.53],0.4303231692108167
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23040,280,0.95 [0.83-1.09],0.47097942707695
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Endometriosis,17590,148,0.95 [0.79-1.15],0.5909296808153379
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17776,334,0.87 [0.76-0.99],0.0331189313165477
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18302,860,1.00 [0.93-1.08],0.9905020011660348
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18201,4230,1.01 [0.97-1.04],0.6359130246568971
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23309,51,1.24 [0.95-1.61],0.1104297701991004
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21486,176,0.79 [0.65-0.97],0.0232617913374374
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22978,339,1.02 [0.91-1.15],0.7042705131843523
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Irregular menses,23056,107,0.78 [0.61-1.00],0.051177732910584
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Menorrhagia,17705,263,0.91 [0.79-1.05],0.1932352032857317
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20568,67,1.23 [0.99-1.54],0.066045960769782
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19514,2072,0.98 [0.94-1.03],0.49267799945405
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17557,115,0.97 [0.79-1.20],0.8024863116928647
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23446,56,1.17 [0.90-1.51],0.2412693295512202
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23446,65,1.19 [0.94-1.52],0.155447396393756
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22381,1880,1.02 [0.97-1.08],0.3762176759310224
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20907,406,1.05 [0.94-1.17],0.3533404493543162
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22858,98,0.91 [0.71-1.16],0.4439534875191148
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23407,315,0.99 [0.87-1.13],0.9278398130244028
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23405,76,1.00 [0.78-1.30],0.9839503690808956
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22106,1605,1.02 [0.97-1.08],0.3924873654844886
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22814,175,1.02 [0.86-1.20],0.855215297385336
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17577,135,1.00 [0.82-1.21],0.987751767274799
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17773,331,0.95 [0.84-1.08],0.4419124384788326
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17539,97,0.99 [0.79-1.24],0.9305540380500396
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17616,174,1.04 [0.89-1.23],0.6075244230529935
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21529,219,0.83 [0.70-0.99],0.0421248484826481
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23194,102,1.07 [0.86-1.32],0.5544964063593929
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17702,260,1.00 [0.87-1.15],0.9860352596365182
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17532,90,0.89 [0.69-1.15],0.3646286065185573
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,17979,537,0.97 [0.88-1.07],0.5048044386487789
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17579,137,1.06 [0.89-1.28],0.508244287094991
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17937,495,0.94 [0.85-1.04],0.2528666613276437
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23292,34,0.74 [0.46-1.18],0.2060562111029042
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23308,1998,1.01 [0.96-1.06],0.7575773162113321
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21453,143,0.97 [0.80-1.17],0.7237697355337569
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21678,77,1.14 [0.90-1.44],0.2931084076796524
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23155,31,1.07 [0.74-1.57],0.7118585877878012
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20627,126,1.05 [0.87-1.27],0.6201858921311028
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23353,229,1.05 [0.91-1.21],0.5006617629839192
USP47,Ubiquitin carboxyl-terminal hydrolase 47,Chapter XIV Diseases of the genitourinary system,Uterine polyps,17560,118,1.00 [0.82-1.23],0.986446111732397
